International E-publication: Publish Projects, Dissertation, Theses, Books, Souvenir, Conference Proceeding with ISBN.  International E-Bulletin: Information/News regarding: Academics and Research

Cassia fistula Linn (Khiyar Sambhar): A traditional Unani medicine with different pharmacological activities

Author Affiliations

  • 1Dept of Amraze Niswan wa Qabalat (OBG), National Institute of Unani Medicine, Bangalore, Karnataka, India
  • 2Dept of Atfal (Pediatrics), Govt. Unani Medical College, Chennai, India
  • 3Dept. of Ilmus Saidla (Pharmacy), National Institute of Unani Medicine, Bangalore, Karnataka, India

Res. J. of Pharmaceutical Sci., Volume 7, Issue (2), Pages 6-9, December,30 (2018)


Cassia fistula is also well-known as Linn Golden shower. Since ancient times, it used as a medicine in the healthcare system. In the Unani system of medicine, it was used to get rid of evil spirits and has been used to cure the root cause of diseases hence it was termed as a sky. This article attempts to search and accumulate the diverse traditional Unani properties of Cassia fistula and to report till date its pharmacological actions. It is a tree of 6-9m.high that belongs to the Fabaceae family. Different part of this tree such as bark, leaves, pod, fruit pulp, and flower are used in various diseases. It is extensively cultivated in Brazil, East Africa, Mexico, and South Africa. In traditional Unani medicine, it is used in various diseases of central nervous, respiratory, cardiovascular, gastrointestinal, urogenital, integument and locomotor systems. It is useful in headache, leprosy, syphilis, arthritis, fever, dysmenorrhoea, post dated pregnancy, constipation, pharyngitis, and eye diseases. Classically, it has emmenagogue, abortifacient, anti-inflammatory, carminative, analgesic, and laxative actions. Currently, it's pharmacologically and biologically activities in animal models such as antibacterial, antifungal, antidiabetic, anti-inflammatory, antioxidant, hepatoprotective, antifertility, wound healing and anticancerous properties are proven. Further, clinical trials are suggested to prove its aforementioned pharmacological activities in humans.


  1. Ghani N. (2001)., Khazainul Advia, Idarae Kitabus Shifa., New Delhi, India, 264-7.
  2. Khan A.M. (2012)., Muhit-i-A` zam, Part I, , Central Council for Research in Unani Medicine, New Delhi, 417, 665-6.
  3. Rao A.N. and Wee W.C. (1989)., Singapore Trees, , Singapore Institute of Biology, Singapore, 357.
  4. Anonymous (1997)., Standardization of single drugs of Unani Medicine, Part II & III, , Central Council for Research in Unani Medicine, New Delhi, India, 247-53, 151-5.
  5. Bhalerao S.A. and Kelkar T.S. (2012)., Traditional medicinal uses, phytochemical profile and pharmacological activities of Cassia fistula Linn., I. Res. J. Biological Sci, 1(5), 79-84.
  6. Baytar I. (2000). Jami al Mufradat al Advia wal Aghzia (Urdu Translation), Vol. I, , Central Council for Research in Unani Medicine, New Delhi, India, 233-4., undefined
  7. Rafeequddin M. (1985)., Kanzul Advia Mufradat, , Muslim University Press, Aligarh, India, 111-3.
  8. Khare C.P. (2008)., Indian Medicinal Plants: An Illustrated Dictionary., , Springer India (P) Ltd, New Delhi, India, 128.
  9. Magrabhi I.B. (2007)., Kitab al-Fath fi'al-Tadawi, , Dept. of AYUSH, New Delhi, 224, 68.
  10. Hakeem M.A. (2202)., Bustanul Mufradat,, Idarae Kitabus Shifa, New Delhi, India, 87-88.
  11. Kabeeruddin M. (2006)., Biaze Khas al-Maroof Ilaj al-Amraz,, Aijaz Publishing House, New Delhi, India, 355.
  12. Nadkarni K.M. (2009)., Indian Medicinal plant, , Popular Prakashan Pvt. Ltd, Mumbai, India.
  13. Anonymous (2002)., The Wealth of India, , Vol I, Council of Scientific & Industrial Research, New Delhi, India, 158-9.
  14. Kabeeruddin M. (2007)., Makhzanul Mufradat, , Idarae Kitabus Shifa, New Delhi, India, 79.
  15. Kritikar K.R. and Basu B.D. (2006)., Indian Medicinal Plants, , Vol 2, India. International Book Distributors, India, 856-60.
  16. Bahorun T., Bhujan V.S., and Aruoma O.I. (2005)., Phytochemical constituents of Cassia fistula., Afr J Biotechnol, 4(13), 1530-40.
  17. Patil D.D., Mhaske D.K. and Wadhaw M.P. (2012)., Antibacterial and antioxidant, anti-inflammatory study of leaves and bark of Cassia fistula., Int. J. Pharm, 2(1), 401-5.
  18. Kulkarni A., Govindappa M., Ramachand Y.L. and Koka P. (2015)., GC-MS analysis of methanol extract of Cassia fistula and its in-vitro anticancer activity on human prostate cancer cell line., Indo American Journal of Pharmaceutical Research, 5(02), 937-40.
  19. Bhalodia N.R., Nariya P.B. and Shukla V.J. (2012)., In-vitro antibacterial and antifungal activities of Cassia fistula Linn., fruit pulp extracts. AYU, 33(1), 123-9. doi: 10.4103/0974-8520.100329.
  20. Einstein J.W., Rais M.M. and Mohd M.A. (2013)., Comparative evaluation of the anti-diabetic effects of different parts of Cassia fistula Linn, a Southeast Asian plant., Journal of Chemistry, 714063. doi:10.1155/2013/ 714063.
  21. Rizvi A.M., Irshad M., Hassadi G.E. and Younis S.B. (2009)., Bioefficacies of Cassia fistula: An Indian labrum., Afr. J. Pharm. Pharmacol, 3(6), 287-92.
  22. Irshad Shreaz S., Manzoor N., Khan L.A. and Rizvi M.M. (2011)., Anticandidal activity of Cassia fistula and its effect on ergosterol biosynthesis., Pharm Biol., 49(7), 727-33. doi: 10.3109/13880209.2010.544318.
  23. Dawada S., Zade V., Dabhadkar D. and Pare S. (2012)., Hepatoprotective activity of Cassia fistula root against Carbon tetrachloride-Induced hepatic injury in rats (Wistar)., International Journal of Pharma Sciences and Research, 3(4), 368-78.
  24. Joshi T., Agarwal M., Singh T., Husain S., Pruthi T. and Rachana (2016)., Anti-diabetic and other pharmacological activities of Cassia fistula., International Journal of Advanced Technology in Engineering and Science, 4(6), 1-10.